Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements.
暂无分享,去创建一个
[1] S. Wutzler,et al. Vascular endothelial growth factor (VEGF165) plus basic fibroblast growth factor (bFGF) producing cells induce a mature and stable vascular network--a future therapy for ischemically challenged tissue. , 2011, The Journal of surgical research.
[2] C. V. van Blitterswijk,et al. Pro-osteogenic trophic effects by PKA activation in human mesenchymal stromal cells. , 2011, Biomaterials.
[3] B. W. van Balkom,et al. Transcriptome analysis in endothelial progenitor cell biology. , 2011, Antioxidants & redox signaling.
[4] D. Prockop,et al. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages. , 2011, Blood.
[5] John D Lambris,et al. Mesenchymal Stromal Cells Engage Complement and Complement Receptor Bearing Innate Effector Cells to Modulate Immune Responses , 2011, PloS one.
[6] A. Ho,et al. Synergistic effects of growth factors and mesenchymal stromal cells for expansion of hematopoietic stem and progenitor cells. , 2011, Experimental hematology.
[7] D. Mougiakakos,et al. The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. , 2011, Blood.
[8] B. Sacchetti,et al. Osteoprogenitors and the hematopoietic microenvironment. , 2011, Best practice & research. Clinical haematology.
[9] J. Motlík,et al. Mapping of the secretome of primary isolates of mammalian cells, stem cells and derived cell lines , 2011, Proteomics.
[10] P. Menasché. Cardiac cell therapy: lessons from clinical trials. , 2011, Journal of molecular and cellular cardiology.
[11] A. Caplan,et al. Mesenchymal stem cells: mechanisms of inflammation. , 2011, Annual review of pathology.
[12] M. Andreeff,et al. Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth? , 2010, Stem cells.
[13] B. Lévy,et al. Endothelial nitric oxide synthase overexpression restores the efficiency of bone marrow mononuclear cell-based therapy. , 2011, The American journal of pathology.
[14] A. Agarwal,et al. Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1. , 2011, American journal of physiology. Renal physiology.
[15] Gwang Lee,et al. Enhancing trophic support of mesenchymal stem cells by ex vivo treatment with trophic factors , 2010, Journal of the Neurological Sciences.
[16] Heesang Song,et al. Overexpression of phosphoinositide-3-kinase class II alpha enhances mesenchymal stem cell survival in infarcted myocardium. , 2010, Biochemical and biophysical research communications.
[17] R. Handgretinger,et al. Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. , 2010, Blood.
[18] Yun Ho Jang,et al. Mesenchymal stem cells' interaction with skin: Wound‐healing effect on fibroblast cells and skin tissue , 2010, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[19] J. I. Izpisúa Belmonte,et al. Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents. , 2010, Journal of molecular and cellular cardiology.
[20] Jeff W M Bulte,et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. , 2010, Archives of neurology.
[21] D. Hommes,et al. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study , 2010, Gut.
[22] M. Toungouz,et al. Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions. , 2010, Experimental hematology.
[23] A. Caplan,et al. Topical delivery of mesenchymal stem cells and their function in wounds , 2010, Stem Cell Research & Therapy.
[24] Gen Suzuki,et al. Activation of host tissue trophic factors through JAK-STAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair. , 2010, American journal of physiology. Heart and circulatory physiology.
[25] D. Prockop,et al. Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury , 2010, Proceedings of the National Academy of Sciences.
[26] J. Adamowicz,et al. N48 TISSUE ENGINEERING OF THE URINARY BLADDER: TROPHIC EFFECTS OF MESENCHYMAL STEM CELLS IN RECONSTRUCTION OF THE RAT BLADDER WALL , 2010 .
[27] R. Rosenwasser,et al. Changes in Host Blood Factors and Brain Glia Accompanying the Functional Recovery after Systemic Administration of Bone Marrow Stem Cells in Ischemic Stroke Rats , 2010, Cell transplantation.
[28] E. Burchardt,et al. Upper extremity ischemia treated with tissue repair cells from adult bone marrow. , 2010, Journal of vascular surgery.
[29] A. Terzic,et al. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. , 2010, Journal of the American College of Cardiology.
[30] N. Gibran,et al. Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. , 2010, Experimental cell research.
[31] Ben D. MacArthur,et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche , 2010, Nature.
[32] Nikolay Bazhanov,et al. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties , 2010, Proceedings of the National Academy of Sciences.
[33] Huipin Yuan,et al. Osteoinductive ceramics as a synthetic alternative to autologous bone grafting , 2010, Proceedings of the National Academy of Sciences.
[34] K. Meldrum,et al. Therapeutic applications of mesenchymal stem cells to repair kidney injury. , 2010, The Journal of urology.
[35] E. Lombardo,et al. Modulation of Adult Mesenchymal Stem Cells Activity by Toll-Like Receptors: Implications on Therapeutic Potential , 2010, Mediators of inflammation.
[36] P. Blankestijn,et al. Progenitor cells and vascular function are impaired in patients with chronic kidney disease. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[37] K. Matrougui,et al. Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice , 2010, Laboratory Investigation.
[38] Ruth S. Waterman,et al. A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype , 2010, PloS one.
[39] S. Kim,et al. Factors affecting graft and patient survival after live donor kidney transplantation in the UK. , 2010 .
[40] Min Young Kim,et al. Proteomic analysis of tumor necrosis factor-alpha-induced secretome of human adipose tissue-derived mesenchymal stem cells. , 2010, Journal of proteome research.
[41] Alan Wells,et al. Epidermal Growth Factor (EGF) Treatment on Multipotential Stromal Cells (MSCs). Possible Enhancement of Therapeutic Potential of MSC , 2010, Journal of biomedicine & biotechnology.
[42] S. Totey,et al. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease. , 2010, Translational research : the journal of laboratory and clinical medicine.
[43] L. Perl,et al. Cellular therapy in 2010: focus on autoimmune and cardiac diseases. , 2010, The Israel Medical Association journal : IMAJ.
[44] Xuejun Wu,et al. Erythropoietin augments the efficacy of therapeutic angiogenesis induced by allogenic bone marrow stromal cells in a rat model of limb ischemia , 2010, Molecular Biology Reports.
[45] Gen Suzuki,et al. Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair. , 2009, Biochemical and biophysical research communications.
[46] Xiaohong Wang,et al. Hsp20‐Engineered Mesenchymal Stem Cells Are Resistant to Oxidative Stress via Enhanced Activation of Akt and Increased Secretion of Growth Factors , 2009, Stem cells.
[47] N. Imai,et al. Innovation in the Treatment of Uremia: Proceedings from the Cleveland Clinic Workshop: Cellular Therapy of Kidney Diseases , 2009, Seminars in dialysis.
[48] P. Conte,et al. Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation. , 2009, Blood.
[49] M. Baker. Stem-cell drug fails crucial trials , 2009 .
[50] P. Delafontaine,et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. , 2009, Cell stem cell.
[51] G. Watzek,et al. Activated platelets increase fibrinolysis of mesenchymal progenitor cells , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[52] A. Faussat,et al. Evaluation of the effect of autologous mesenchymal stem cell injection in a large‐animal model of bilateral kidney ischaemia reperfusion injury , 2009, Cell proliferation.
[53] D. Weiss,et al. Cell therapy approaches for lung diseases: current status. , 2009, Current opinion in pharmacology.
[54] M. Tendera,et al. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem , 2009, European heart journal.
[55] N. Rouas-Freiss,et al. HLA-G is a Crucial Immunosuppressive Molecule Secreted by Adult Human Mesenchymal Stem Cells , 2009, Transplantation.
[56] Philippe M. Campeau,et al. Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner1 , 2009, The Journal of Immunology.
[57] S. Miller,et al. Molecular mechanisms of T‐cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy , 2009, Immunological reviews.
[58] Gen Suzuki,et al. Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen. , 2009, American journal of physiology. Heart and circulatory physiology.
[59] A. Cohen,et al. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. , 2009, Stem cells and development.
[60] Ming Zhao,et al. C3a and C5a Are Chemotactic Factors for Human Mesenchymal Stem Cells, Which Cause Prolonged ERK1/2 Phosphorylation1 , 2009, The Journal of Immunology.
[61] R. Pochampally,et al. Multipotent Stromal Cells Are Activated to Reduce Apoptosis in Part by Upregulation and Secretion of Stanniocalcin‐1 , 2009 .
[62] Manuel A. González,et al. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. , 2009, Gastroenterology.
[63] S. Fazel,et al. Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3-deficient mice. , 2009, The Journal of thoracic and cardiovascular surgery.
[64] A. Caplan. Why are MSCs therapeutic? New data: new insight , 2009, The Journal of pathology.
[65] D. García-Olmo,et al. Expanded Adipose-Derived Stem Cells for the Treatment of Complex Perianal Fistula: a Phase II Clinical Trial , 2009, Diseases of the colon and rectum.
[66] I. Manabe,et al. IFATS Collection: Fibroblast Growth Factor‐2‐Induced Hepatocyte Growth Factor Secretion by Adipose‐Derived Stromal Cells Inhibits Postinjury Fibrogenesis Through a c‐Jun N‐Terminal Kinase‐Dependent Mechanism , 2009, Stem cells.
[67] M. L. Bringas-Vega,et al. Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study. , 2009, Restorative neurology and neuroscience.
[68] Winfried Wiegraebe,et al. Detection of functional haematopoietic stem cell niche using real-time imaging , 2009, Nature.
[69] David W. Rowe,et al. Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche , 2009, Nature.
[70] Krisztián Németh,et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production , 2009, Nature Medicine.
[71] G. Condorelli,et al. Vascular endothelial growth factors in cardiovascular medicine , 2008, Journal of cardiovascular medicine.
[72] P. Doevendans,et al. Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results , 2008, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.
[73] E. Geissler,et al. Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate. , 2008, Transplant immunology.
[74] H. Huikuri,et al. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. , 2008, European heart journal.
[75] K. Houkin,et al. Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats , 2008, Brain Research.
[76] W. Brenner,et al. Pilot Trial on Determinants of Progenitor Cell Recruitment to the Infarcted Human Myocardium , 2008, Circulation.
[77] N. Perico,et al. Pretransplant Infusion of Mesenchymal Stem Cells Prolongs the Survival of a Semiallogeneic Heart Transplant through the Generation of Regulatory T Cells1 , 2008, The Journal of Immunology.
[78] S. Badylak,et al. A perivascular origin for mesenchymal stem cells in multiple human organs. , 2008, Cell stem cell.
[79] A. Uccelli,et al. Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.
[80] N. Nardi,et al. In Search of the In Vivo Identity of Mesenchymal Stem Cells , 2008, Stem cells.
[81] N. Perico,et al. Human Bone Marrow Mesenchymal Stem Cells Accelerate Recovery of Acute Renal Injury and Prolong Survival in Mice , 2008, Stem cells.
[82] Gen Suzuki,et al. Assessment of a Nuclear Affinity Labeling Method for Tracking Implanted Mesenchymal Stem Cells , 2008, Cell transplantation.
[83] Y. Shiozawa,et al. Hematopoietic Stem Cells Regulate Mesenchymal Stromal Cell Induction into Osteoblasts Thereby Participating in the Formation of the Stem Cell Niche , 2008, Stem cells.
[84] H. Friess,et al. VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma , 2008, British Journal of Cancer.
[85] G. Camussi,et al. Contribution of Stem Cells to Kidney Repair , 2008, American Journal of Nephrology.
[86] S. Setty,et al. IFN‐γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease , 2008, European journal of immunology.
[87] Joyce Doorn,et al. cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo , 2008, Proceedings of the National Academy of Sciences.
[88] G. Dini,et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study , 2008, The Lancet.
[89] D. Meldrum,et al. Surgically relevant aspects of stem cell paracrine effects. , 2008, Surgery.
[90] M. Andreeff,et al. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells , 2008, Gene Therapy.
[91] Liwen Chen,et al. Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing , 2008, PloS one.
[92] Ling Wei,et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. , 2008, The Journal of thoracic and cardiovascular surgery.
[93] H. Lee,et al. The Anti‐Inflammatory and Anti‐Angiogenic Role of Mesenchymal Stem Cells in Corneal Wound Healing Following Chemical Injury , 2008, Stem cells.
[94] D. Scadden,et al. Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. , 2008, Cell stem cell.
[95] Meijing Wang,et al. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. , 2008, American journal of physiology. Cell physiology.
[96] H. Shimizu,et al. Mesenchymal Stem Cells Are Recruited into Wounded Skin and Contribute to Wound Repair by Transdifferentiation into Multiple Skin Cell Type1 , 2008, The Journal of Immunology.
[97] R. Zhao,et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell Stem Cell.
[98] E. Gócza,et al. Mesenchymal Stem Cells Cooperate with Bone Marrow Cells in Therapy of Diabetes , 2008, Stem cells.
[99] L. Fouillard,et al. Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression. , 2008, Cellular immunology.
[100] Y. Yoon,et al. Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart , 2007, The Journal of experimental medicine.
[101] Lina A. Thoren,et al. Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. , 2007, Cell stem cell.
[102] J. Rossignol,et al. A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. , 2007, Blood.
[103] S. Ho,et al. Post-injury regeneration in rat sciatic nerve facilitated by neurotrophic factors secreted by amniotic fluid mesenchymal stem cells , 2007, Journal of Clinical Neuroscience.
[104] A. Caplan. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine , 2007, Journal of cellular physiology.
[105] G. Remuzzi,et al. Insulin-like growth factor-1 sustains stem cell mediated renal repair. , 2007, Journal of the American Society of Nephrology : JASN.
[106] Ross Tubo,et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.
[107] Paul G Scott,et al. Mesenchymal Stem Cells Enhance Wound Healing Through Differentiation and Angiogenesis , 2007, Stem cells.
[108] C. Huet,et al. New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. , 2007, Regenerative medicine.
[109] L. Cantley,et al. Stromal cells protect against acute tubular injury via an endocrine effect. , 2007, Journal of the American Society of Nephrology : JASN.
[110] R. Pochampally,et al. Angiogenic Effects of Human Multipotent Stromal Cell Conditioned Medium Activate the PI3K‐Akt Pathway in Hypoxic Endothelial Cells to Inhibit Apoptosis, Increase Survival, and Stimulate Angiogenesis , 2007, Stem cells.
[111] M. Araie,et al. Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration. , 2007, Experimental eye research.
[112] L. Fouillard,et al. Immunosuppressive Effects of Mesenchymal Stem Cells: Involvement of HLA-G , 2007, Transplantation.
[113] Jianhua Wang,et al. Annexin II expressed by osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantation. , 2007, Blood.
[114] V. Falanga,et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. , 2007, Tissue engineering.
[115] Ping Chen,et al. Mesenchymal stem cells modified with angiopoietin-1 improve remodeling in a rat model of acute myocardial infarction. , 2007, Biochemical and biophysical research communications.
[116] M. Ashraf,et al. HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia. , 2007, Journal of molecular and cellular cardiology.
[117] P. Boor,et al. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. , 2007, Journal of the American Society of Nephrology : JASN.
[118] Darwin J. Prockop,et al. Short-Term Exposure of Multipotent Stromal Cells to Low Oxygen Increases Their Expression of CX3CR1 and CXCR4 and Their Engraftment In Vivo , 2007, PloS one.
[119] Andrea T. Badillo,et al. Enhanced epithelial gap closure and increased angiogenesis in wounds of diabetic mice treated with adult murine bone marrow stromal progenitor cells , 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[120] Florian Tögel,et al. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. , 2007, American journal of physiology. Renal physiology.
[121] K. Osterziel. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1 year results of the REPAIR-AMI trial. , 2006, European heart journal.
[122] L. Fouillard,et al. Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. , 2006, Gene expression.
[123] S. Baranzini,et al. The molecular signature of therapeutic mesenchymal stem cells exposes the architecture of the hematopoietic stem cell niche synapse , 2007, BMC Genomics.
[124] Shiqiang Yu,et al. Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft. , 2006, Transplantation proceedings.
[125] R. Yañez,et al. Adipose Tissue‐Derived Mesenchymal Stem Cells Have In Vivo Immunosuppressive Properties Applicable for the Control of the Graft‐Versus‐Host Disease , 2006, Stem cells.
[126] H. Haider,et al. Supportive Interaction Between Cell Survival Signaling and Angiocompetent Factors Enhances Donor Cell Survival and Promotes Angiomyogenesis for Cardiac Repair , 2006, Circulation research.
[127] Xiaobing Fu,et al. Adult bone-marrow-derived mesenchymal stem cells contribute to wound healing of skin appendages , 2006, Cell and Tissue Research.
[128] H. Anders,et al. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. , 2006, Kidney international.
[129] K. McFarlin,et al. Bone marrow‐derived mesenchymal stromal cells accelerate wound healing in the rat , 2006, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[130] G. Koehl,et al. Immunomodulatory Effects of Mesenchymal Stem Cells in a Rat Organ Transplant Model , 2006, Transplantation.
[131] David Klatzmann,et al. Bone Marrow Mesenchymal Stem Cells Suppress Lymphocyte Proliferation In Vitro but Fail to Prevent Graft-versus-Host Disease in Mice1 , 2006, The Journal of Immunology.
[132] M. Ashraf,et al. Bone Marrow Stem Cells Prevent Left Ventricular Remodeling of Ischemic Heart Through Paracrine Signaling , 2006, Circulation research.
[133] I. Komuro,et al. Critical Roles of Muscle-Secreted Angiogenic Factors in Therapeutic Neovascularization , 2006, Circulation research.
[134] K. Houkin,et al. Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat , 2006, Experimental Neurology.
[135] S. Carmichael. Cellular and molecular mechanisms of neural repair after stroke: Making waves , 2006, Annals of neurology.
[136] T. Yokoo,et al. Xenobiotic kidney organogenesis from human mesenchymal stem cells using a growing rodent embryo. , 2006, Journal of the American Society of Nephrology : JASN.
[137] Sergio Romagnani,et al. Role for Interferon‐γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells , 2006 .
[138] P. Frenette,et al. Signals from the Sympathetic Nervous System Regulate Hematopoietic Stem Cell Egress from Bone Marrow , 2006, Cell.
[139] J. Kriz. Inflammation in ischemic brain injury: timing is important. , 2006, Critical reviews in neurobiology.
[140] D. Prockop,et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.
[141] F. Benvenuto,et al. Human mesenchymal stem cells modulate B-cell functions. , 2006, Blood.
[142] K. Houkin,et al. I.v. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat , 2005, Neuroscience.
[143] D. Prockop,et al. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[144] D. Link,et al. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. , 2005, Blood.
[145] S. Rafii,et al. The bone marrow vascular niche: home of HSC differentiation and mobilization. , 2005, Physiology.
[146] S. Morrison,et al. Supplemental Experimental Procedures , 2022 .
[147] Y. Ko,et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size , 2005, The Journal of experimental medicine.
[148] Yi Zhang,et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. , 2005, Blood.
[149] F. Tögel,et al. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. , 2005, Kidney international.
[150] H. Matsuda,et al. Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts. , 2005, American journal of physiology. Heart and circulatory physiology.
[151] J. Canty,et al. Adenoviral Gene Transfer of FGF-5 to Hibernating Myocardium Improves Function and Stimulates Myocytes to Hypertrophy and Reenter the Cell Cycle , 2005, Circulation research.
[152] D. Mevorach,et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. , 2005, Blood.
[153] M. Pittenger,et al. Human mesenchymal stem cells modulate allogeneic immune cell responses. , 2005, Blood.
[154] C. Lange,et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. , 2005, American journal of physiology. Renal physiology.
[155] K. Houkin,et al. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[156] G. Camussi,et al. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. , 2004, International journal of molecular medicine.
[157] J. Rothstein,et al. Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors , 2004, Molecular and Cellular Neuroscience.
[158] Keisuke Ito,et al. Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche , 2004, Cell.
[159] M. Chopp,et al. Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. , 2004, Journal of neurotrauma.
[160] N. Perico,et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. , 2004, Journal of the American Society of Nephrology : JASN.
[161] Ulrich Göbel,et al. bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 20, 2013. For personal use , 2004 .
[162] Moustapha Hassan,et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells , 2004, The Lancet.
[163] I. Weissman,et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium , 2004, Nature.
[164] Keith L. March,et al. Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells , 2004, Circulation.
[165] K. Houkin,et al. Comparative analysis of remyelinating potential of focal and intravenous administration of autologous bone marrow cells into the rat demyelinated spinal cord , 2003, Glia.
[166] Haiyang Huang,et al. Identification of the haematopoietic stem cell niche and control of the niche size , 2003, Nature.
[167] Robert A. Kloner,et al. Systemic Delivery of Bone Marrow–Derived Mesenchymal Stem Cells to the Infarcted Myocardium: Feasibility, Cell Migration, and Body Distribution , 2003, Circulation.
[168] Elizabeth Simpson,et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. , 2003, Blood.
[169] D. Bodine,et al. Bone marrow stem cells regenerate infarcted myocardium , 2003, Pediatric transplantation.
[170] J. Kocsis,et al. Remyelination of the spinal cord following intravenous delivery of bone marrow cells , 2002, Glia.
[171] M. Chopp,et al. Human marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery , 2002, Neurology.
[172] S. Rafii,et al. Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.
[173] C. Carlo-Stella,et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.
[174] S. Burakoff,et al. Cytolytic pathways in haematopoietic stem-cell transplantation , 2002, Nature Reviews Immunology.
[175] Kevin McIntosh,et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. , 2002, Experimental hematology.
[176] C. Overall,et al. Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1* , 2001, The Journal of Biological Chemistry.
[177] R. Poulsom,et al. Bone marrow contributes to renal parenchymal turnover and regeneration , 2001, The Journal of pathology.
[178] S. Nilsson,et al. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. , 2001, Blood.
[179] M. Chopp,et al. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats , 2001, Journal of the Neurological Sciences.
[180] A. Caplan,et al. Cultivation of rat marrow‐derived mesenchymal stem cells in reduced oxygen tension: Effects on in vitro and in vivo osteochondrogenesis , 2001, Journal of cellular physiology.
[181] K Walsh,et al. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. , 2001, Journal of molecular and cellular cardiology.
[182] I. Fischer,et al. In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. , 2001, Biochemical and biophysical research communications.
[183] S. Watt,et al. Adhesion receptors on haematopoietic progenitor cells , 2001, British journal of haematology.
[184] I. Black,et al. Adult rat and human bone marrow stromal cells differentiate into neurons , 2000, Journal of neuroscience research.
[185] B. Molitoris,et al. Acute renal failure in the new millennium: time to consider combination therapy. , 2000, Seminars in nephrology.
[186] E. Hirsch,et al. FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces, In Vitro, Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial Cells , 1999, The Journal of Neuroscience.
[187] A I Caplan,et al. Cytokine expression by human marrow‐derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL‐1α , 1996, Journal of cellular physiology.
[188] R. Taichman,et al. Human osteoblasts support human hematopoietic progenitor cells in vitro bone marrow cultures. , 1996, Blood.
[189] E. Hirsch,et al. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease , 1994, Neuroscience Letters.
[190] T. Dexter,et al. The role of growth factors in self-renewal and differentiation of haemopoietic stem cells. , 1990, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[191] T. Dexter. Haemopoietic growth factors. , 1986, British medical bulletin.
[192] R. Schofield. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. , 1978, Blood cells.
[193] A. Leaf. Cell Swelling: A Factor in Ischemic Tissue Injury , 1973, Circulation.